Singapore markets close in 3 hours 51 minutes

Theratechnologies Inc. (THTX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.3600+0.0200 (+1.49%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.3400
Open1.3700
Bid0.9864 x 200
Ask1.7600 x 200
Day's range1.3200 - 1.4200
52-week range0.8800 - 4.3200
Volume20,136
Avg. volume36,017
Market cap62.533M
Beta (5Y monthly)1.78
PE ratio (TTM)N/A
EPS (TTM)-0.9100
Earnings date10 Jul 2024 - 15 Jul 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.67
  • Zacks

    Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock?

    Theratechnologies (THTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • GlobeNewswire

    Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

    MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company has mailed its 2024 management proxy circular to shareholders in connection with its virtual annual meeting of shareholders to be held on May 9, 2024, at 10:00 a.m. ET. Shareholders are encouraged to vote their shares for the propos

  • GlobeNewswire

    Theratechnologies to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

    MONTREAL, April 11, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company’s President and CEO, Paul Lévesque will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference, which is taking place April 16-17 in Toronto, Canada. Presentation Details: Date/Time:Wednesday, April 17, 2024, at